康宁杰瑞制药-B(09966)拟回购最高3000万港元的股份

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a decision by its board to repurchase up to HKD 30 million of its ordinary shares from the open market, indicating that the current trading price does not accurately reflect the company's intrinsic value [1] Group 1 - The board believes that the share repurchase will demonstrate confidence in the company's business outlook and prospects, ultimately benefiting the company and creating value for its shareholders [1] - The company asserts that its current financial resources are sufficient to support the proposed share repurchase while maintaining a robust financial position [1]